Zobrazeno 1 - 10
of 614
pro vyhledávání: '"SHIGETAKE SASAYAMA"'
Autor:
Norifumi Nakanishi, Nobuhiro Tahara, Satoshi Sakai, Yukio Ozaki, Motonori Hatta, Hiroshi Watanabe, Yoshiaki Okano, Masaru Hatano, Koichiro Yoshioka, Hiroaki Dobashi, Yasuki Kihara, Masakazu Matsushita, Tohru Minamino, Satoshi Ikeda, Masanori Funauchi, Takahisa Kondo, Keiichi Fukuda, Shigetake Sasayama, Shuji Joho, Hidehiro Yamada, Nobuhiro Tanabe, Tsutomu Saji
Publikováno v:
Current medical research and opinion. 36(6)
Objective: Macitentan, a novel dual endothelin receptor antagonist, was approved for the treatment of pulmonary arterial hypertension (PAH) in Japan. However, long-term effects in Japanese patients...
Autor:
Shigetake Sasayama
Publikováno v:
Circulation Journal. 83:1817-1818
Autor:
Keiichi Fukuda, Yasuki Kihara, Masakazu Matsushita, Tohru Minamino, Hiroaki Dobashi, Satoshi Ikeda, Shuji Joho, Nobuhiro Tahara, Hidehiro Yamada, Shigetake Sasayama, Takeshi Kimura, Norifumi Nakanishi, Masanori Funauchi, Satoshi Sakai, Hiroshi Watanabe, Yukio Ozaki, Masaru Hatano, Takahisa Kondo, Koichiro Yoshioka, Nobuhiro Tanabe, Tsutomu Saji
Publikováno v:
Circulation Journal. 80:1478-1483
BACKGROUND Macitentan is a novel, dual endothelin receptor antagonist with sustained receptor binding, used for the long-term treatment of pulmonary arterial hypertension (PAH). In the present study, we assessed the efficacy and safety of macitentan
Autor:
Hiroshi Watanabe, Hiroshi Ito, Toshihisa Anzai, Nobuhiro Tahara, Toru Satoh, Tomotaka Nakayama, Koichiro Kuwahara, Osamu Okazaki, Yutaka Takeda, Koichiro Yoshioka, Keiichi Fukuda, Satoshi Sakai, Teruo Inoue, Mitsugu Taniguchi, Satoshi Ikeda, Takeshi Yamamoto, Yasuchika Takeishi, Nobuhiro Tanabe, Yasuki Kihara, Akiyoshi Hashimoto, Kouji Kajinami, Hideyuki Kinoshita, Toyoaki Murohara, Masaru Hatano, Keiko Yamauchi-Takihara, Shigetake Sasayama
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 81(9)
BACKGROUND Selexipag is an orally available prostacyclin receptor (IP receptor) agonist with a non-prostanoid structure. In this open-label Phase II trial, the efficacy and safety of selexipag in Japanese patients with pulmonary arterial hypertension
Autor:
Shigetake Sasayama
Publikováno v:
Current Heart Failure Reports. 8:155-158
A national survey in Japan has revealed that about one of five adults in the general population suffers from a sleep problem [1]. However, sleep-disordered breathing (SDB) had not been well recognized as a substantial health issue in Japan until Marc
Autor:
Takahide Kohro, Ryozo Nagai, Masatoshi Fujita, Tsutomu Yamazaki, Shigetake Sasayama, Doubun Hayashi, Fumio Terasaki, Satoko Mitani, Yoshihiro Okada, Tatsuya Morimoto
Publikováno v:
Heart and Vessels. 25:453-459
Low-dose antihypertensive drugs in combination are prescribed frequently in clinical practice. Combination treatment is superior to monotherapy with higher doses of each drug in terms of blood pressure reduction and side effects. However, it is uncle
Autor:
Shigetake Sasayama, Masatoshi Fujita
Publikováno v:
Circulation Journal. 74:1283-1289
There is a tremendous body of data concerning the coronary collateral circulation in both experimental animals and humans. The functional importance of a well-developed coronary collateral circulation has now been documented. The paradigm regarding t
Autor:
Lixin Jin, Satz Mengensatzproduktion, Lin Xu, Kenneth J. Nichols, Lianglong Chen, Qing Duan, A. García-Alberola, S. Manzano-Fernández, William A. Bauman, Bin Sun, Andrew Van Tosh, David Rott, M. Sánchez, David Leibowitz, Victor L. Serebruany, Chaim Lotan, Andre Keren, Israel Gotsman, Gonenc Kocabay, Jill M. Wecht, Halil İbrahim Tanboğa, Xunjing Xue, V. Moreno-Flores, Regaip Zehir, Dwindally Rosado-Rivera, Christopher M. Cirnigliaro, Roseline Schwartz, Steven F. Horowitz, Dan Admon, Tai Hing Lam, Solomon Behar, Vassilios Vassilikos, Druck Reinhardt Druck Basel, Arzu Kalayci, Michael F. La Fountaine, Alejandro Díaz, Elke Holinski-Feder, Phyllis G. Supino, Nathaniel Reichek, Ioannis H. Styliadis, Masatoshi Fujita, A. Teddy Weiss, Chao Qiang Jiang, Dahlia Garza, Josef Finsterer, Shigetake Sasayama, Zhiyong Chen, Wei Sen Zhang, Wenbin Ye, Kar Keung Cheng, Hanoch Hod, Can Yücel Karabay, Georgios Stavropoulos, Ann M. Spungen, Aglaia-Angeliki Mantziari, Claudia Stöllberger, Donna R. Zwas, G. Neil Thomas
Publikováno v:
Cardiology. 117:I-VI
Autor:
Tsutomu Yamazaki, Dobun Hayashi, Masatoshi Fujita, Ryozo Nagai, Shigetake Sasayama, Yoshihiro Okada, Satoko Mitani, Takahide Kohro
Publikováno v:
International Heart Journal. 51:299-302
Calcium channel blockers (CCB) and statins are frequently prescribed for patients with coronary artery disease (CAD) complicated by hypertension and/or hypercholesterolemia. CCB have pleiotropic actions beyond their blood pressure-lowering effect, wh
Autor:
Shigetake Sasayama, Tohru Izumi, Masunori Matsuzaki, Akira Matsumori, Hidetsugu Asanoi, Shin-ichi Momomura, Yoshihiko Seino, Kenji Ueshima, null The CHF-HOT Study Group
Publikováno v:
Circulation Journal. 73:1255-1262
Background: Previously, we reported the benefit of 12 weeks of home oxygen therapy (HOT) in patients with central sleep apnea (CSA) and heart failure (HF). In the present study, we attempted to confirm the sustained efficacy of HOT in the long term t